Diamond-Blackfan anemia
Information
- Disease name
- Diamond-Blackfan anemia
- Disease ID
- DOID:1339
- Description
- "A pure red-cell aplasia that is characterized by anemia (low red blood cell counts) with decreased erythroid progenitors in the bone marrow and has_material_basis_insufficient levels of red blood cells due to bone marrow dysfunction." [url:http\://en.wikipedia.org/wiki/Diamond%E2%80%93Blackfan_anemia, url:http\://ghr.nlm.nih.gov/condition/diamond-blackfan-anemia, url:http\://www.cdc.gov/ncbddd/dba/, url:http\://www.omim.org/entry/105650]
Disease area statistics
Chromosome band
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT01966367 | Active, not recruiting | Phase 1/Phase 2 | CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation | March 2013 | February 2030 |
NCT00176878 | Completed | Phase 2/Phase 3 | Stem Cell Transplant for Bone Marrow Failure Syndromes | June 2000 | March 2009 |
NCT00244010 | Completed | N/A | Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias | October 2005 | February 2009 |
NCT00176852 | Completed | Phase 2/Phase 3 | Stem Cell Transplant for Hemoglobinopathy | June 2002 | January 2020 |
NCT00301834 | Completed | Phase 2 | Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders | January 2005 | September 2011 |
NCT00305708 | Completed | Phase 1/Phase 2 | Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission | August 2000 | July 2004 |
NCT00673608 | Completed | Phase 4 | Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron Overload | November 2007 | September 2011 |
NCT00957931 | Completed | Phase 2 | Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs | March 2009 | August 2013 |
NCT01114776 | Completed | Multi-Center Study of Iron Overload: Pilot Study | November 1, 2009 | September 30, 2013 | |
NCT01917708 | Completed | Phase 1 | Bone Marrow Transplant With Abatacept for Non-Malignant Diseases | January 2014 | September 19, 2019 |
NCT01529827 | Completed | Phase 2 | Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies | February 28, 2012 | August 29, 2019 |
NCT01913548 | Completed | Multi-Center Study of Iron Overload: Survey Study (MCSIO) | March 31, 2010 | October 31, 2013 | |
NCT01586455 | Completed | Phase 1 | Human Placental-Derived Stem Cell Transplantation | April 2013 | September 2022 |
NCT04965597 | Recruiting | Phase 2 | Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904) | April 19, 2022 | December 2026 |
NCT02720679 | Recruiting | Investigation of the Genetics of Hematologic Diseases | June 17, 2016 | July 2050 | |
NCT03050268 | Recruiting | Familial Investigations of Childhood Cancer Predisposition | April 6, 2017 | March 31, 2037 | |
NCT03653338 | Recruiting | Phase 1/Phase 2 | T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias | August 2, 2018 | August 1, 2026 |
NCT00290628 | Terminated | N/A | Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer | October 1999 | April 2007 |
NCT01319851 | Terminated | N/A | Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation | September 2010 | September 2013 |
NCT02512679 | Terminated | Phase 2 | Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells | February 2007 | February 2014 |
NCT01419704 | Withdrawn | Phase 1/Phase 2 | Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies | May 2011 | May 2016 |
- Disase is a (Disease Ontology)
- DOID:1340
- Cross Reference ID (Disease Ontology)
- GARD:6274
- Cross Reference ID (Disease Ontology)
- ICD10CM:D61.01
- Cross Reference ID (Disease Ontology)
- MESH:D029503
- Cross Reference ID (Disease Ontology)
- MIM:PS105650
- Cross Reference ID (Disease Ontology)
- NCI:C61236
- Cross Reference ID (Disease Ontology)
- ORDO:124
- Exact Synonym (Disease Ontology)
- Blackfan - Diamond syndrome
- Exact Synonym (Disease Ontology)
- chronic constitutional pure red cell anaemia
- OMIM Phenotype Series Number (OMIM)
- PS105650